Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases-百迪生物科技

首页 > 文献支持 > Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases

Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases

2025-06-08·文献支持

加入收藏去分享

发布日期： 2025-06-08

来源：

作者： Shengke Zhao, Yunjian Yu, Youtao Xin, Hegang Lu, Xiaohui Li a, Shuyu Wang, Feihe Ma, Hui Gao

加入收藏去分享

来源网址：https://www.sciencedirect.com/science/article/abs/pii/S1748013225001148

期刊：nanotoday丨丨引用百迪产品：H901001 1.5mL 微量离心管（PP，锥形底，未灭菌，无酶）& H803001 12孔细胞培养板（PS，TC处理，灭菌，无酶）

IF：13.2

已经是第一篇

日期：2025-05-14

A pH-Sensitive Nanosized Covalent–Organic Polymer for Enhanced Tumor Photodynamic Immunotherapy by Hypoxia Relief and STAT3 Inhibition

解决方案

关于百迪